The Wolf of Winamac (@crawfors77) 's Twitter Profile
The Wolf of Winamac

@crawfors77

Shane Crawford. Multi-Millionaire investor. Never take my opinions as financial advice. I'm an idiot- you can ask anyone. DO YOUR OWN DD. NFA

ID: 1505635080286478342

calendar_today20-03-2022 19:59:23

1,1K Tweet

47 Followers

138 Following

Russell Starr (@russ_n_starr) 's Twitter Profile Photo

1/ The shareholder letter is thoughtful but let’s strip away the words and focus on math. 2/ $DEFT is likely earning $0.16–$0.23 USD/share in 2024, with earnings suppressed by the debatable use of DLOM on DeFi Alpha trades. 3/ 2025 setup: Brazil fully live, potential Africa &

PubCoInsight (@pubcoinsight) 's Twitter Profile Photo

🚨 FORGET NEEDLES. LOOK AT THIS. Wall Street is obsessed with AI chips, but they are missing a quiet revolution in the OTC markets. Imagine detecting cancer with a simple cheek swab. No needles. No painful biopsies. Just mRNA science. Ludwig Enterprises $LUDG isn't just a

PubCoInsight (@pubcoinsight) 's Twitter Profile Photo

πŸ“‰ THE VALUATION GAP: LUDG vs. BIG PHARMA Most investors wait until a stock hits the NASDAQ to buy. By then, the 10x gains are gone. We found a tiny biotech trading for pennies that is holding a patent portfolio capable of challenging the giants. 🧬 The Tech: Non-invasive mRNA

PubCoInsight (@pubcoinsight) 's Twitter Profile Photo

⚠️ RARE "UPLIST ALERT" ISSUED We just released a high-priority research note on Ludwig Enterprises ($LUDG). While the herd chases overvalued tech stocks, LUDG is quietly ticking the boxes for a potential move to a major exchange. * βœ… Validated mRNA Tech * βœ… Massive Patent

PubCoInsight (@pubcoinsight) 's Twitter Profile Photo

THE END OF NEEDLES? WALL STREET IS IGNORING THIS. πŸ§¬πŸš«πŸ’‰ Forget invasive biopsies. Forget painful blood draws. πŸ‘‰ Ludwig Enterprises $LUDG is developing proprietary mRNA technology that detects cancer & inflammation using a simple cheek swab. Why this matters: β€’ No needles β€’ No

THE END OF NEEDLES? WALL STREET IS IGNORING THIS. πŸ§¬πŸš«πŸ’‰
Forget invasive biopsies.
Forget painful blood draws.
πŸ‘‰ Ludwig Enterprises $LUDG is developing proprietary mRNA technology that detects cancer & inflammation using a simple cheek swab.
Why this matters:
β€’ No needles
β€’ No
Russell Starr (@russ_n_starr) 's Twitter Profile Photo

$DEFT - now trading at cash (165 mln USD) plus privates (40 mln USD - this is a Crypto Swiss bank position - incredibly strategic) and annual revs of about 100 mln USD. If this is not taken out I will be shocked. Current market conditions are garbage but management is doing

The Wolf of Winamac (@crawfors77) 's Twitter Profile Photo

$LUDG πŸ“· Breaking out? Rumors swirling of an S1 filing + NASDAQ uplist coming as early as this week. They have the funding and the AI/mRNA Cancer patents to back it up. Commercial site is live. Get in before the news hits the wires. πŸ“·